{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT01124006: Phase 2 Interventional Completed Degenerative Disc Disease
(2010)
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Source:
NCT04535674: Phase 2 Interventional Completed COVID-19 Induced Pneumonia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00413205: Phase 2 Interventional Completed Emphysema
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
Am Heart J. Feb 2009;157(2):271-7.: Phase 3 Human clinical trial Completed Heart Failure/epidemiology
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02657915: Phase 2 Interventional Completed Acute Optic Neuritis
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03694522: Phase 2 Interventional Completed Gastric Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04587830: Phase 2 Interventional Recruiting Glioblastoma Multiforme (GBM)
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03290781: Phase 3 Interventional Completed Ulcerative Colitis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:lutetium (¹⁷⁷Lu) lilotomab satetraxetan [INN]
Source URL:
Class:
PROTEIN
